Bioqual, Inc.
BIOQ · OTC
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.12 | -3.20 | -0.97 | -0.70 |
| FCF Yield | 6.72% | 13.50% | 8.77% | -7.30% |
| EV / EBITDA | 76.40 | 17.45 | 11.43 | 5.36 |
| Quality | ||||
| ROIC | -2.93% | -0.04% | 1.44% | 9.22% |
| Gross Margin | -3.88% | 12.68% | 20.11% | 19.66% |
| Cash Conversion Ratio | -2.81 | 19.36 | 9.85 | 0.06 |
| Growth | ||||
| Revenue 3-Year CAGR | -7.95% | -3.96% | 2.80% | 12.58% |
| Free Cash Flow Growth | -69.12% | 46.34% | 230.97% | -102.12% |
| Safety | ||||
| Net Debt / EBITDA | -2.58 | -3.96 | 1.63 | 1.12 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 84.69 | 77.39 | 112.55 | 125.08 |